ArticleLung Cancer (Auckland, N.Z.)2018

Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden.

Ankur R Parikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.